Table 1 Baseline characteristics of CABG and PCI samples
Variables | PCI population—410 | CABG—559 | P value |
|---|---|---|---|
Age (IQR) | 61 (54–67) | 63 (57–69) | < 0.001 |
Male sex (%) | 258 (62.9) | 398 (71.2) | < 0.001 |
Hypertension (%) | 331 (80.9) | 444 (79.4) | 0.564 |
Diabetes (%) | 247 (60.2) | 287 (51.3) | 0.006 |
Smoke history (%) | 179 (43.7) | 308 (55.1) | < 0.001 |
EF (IQR) | 62.5 (58–69) | 60 (51–64) | < 0.001 |
SYNTAX score I (IQR) | 14 (10–19.1) | 23 (17–29.5) | < 0.001 |
Residual SYNTAX score (IQR) | 4.7 (0–9) | 2 (0–6.5) | < 0.001 |
SYNTAX score II (IQR) | 28.7 (23–34.2) | 25.4 (19.2–32.8) | < 0.001 |
PAD (%) | 22 (5.4) | 67 (12) | < 0.001 |
COPD (%) | 6 (1.5) | 27 (4.8) | 0.004 |
GFR (IQR) | 67 (57–80) | 69 (58–79) | 0.514 |
LDL (IQR) | 117 (89–145) | 106 (83–134) | 0.002 |
Aspirin/clopidogrel (%) | 406 (99) | 553 (98.9%) | 0.882 |
Statin (%) | 400 (97.6) | 553 (98.9%) | 0.099 |
Three-vessel disease (%) | 215 (51) | 220 (39.4) | < 0.001 |
Left-main (%) | 15 (3.7) | 116 (20.8) | < 0.001 |
Complete revascularization (%) | 106 (25.9) | 224 (40.1) | < 0.001 |
Drug eluting stent (%) | 152 (37.1) | N.A | – |
On-pump CABG (%) | NA | 323 (57.8) | – |
Left internal thoracic artery (%) | NA | 546 (97.7) | – |
Second arterial graft (%) | NA | 69 (12.3) | – |
Number of grafts (SD) | NA | 2.9 (± 0.64) | – |